Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia

International Journal of Gynecology and Obstetrics

Volumn 115, Issue 1, 2011, Pages 37-39

  Cyriac, Sanju ^a   Rajendranath, Rejiv ^a   Sridevi, Veluswami ^a   Sagar, Tenali G ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

Chemotherapy; Etoposide, cisplatin etoposide, methotrexate, actinomycin D; Salvage; Trophoblastic disease

Indexed keywords

CISPLATIN; DACTINOMYCIN; ETOPOSIDE; METHOTREXATE;

ADULT; ANEMIA; ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; HIGH RISK POPULATION; HUMAN; LIVER DYSFUNCTION; LIVER METASTASIS; LUNG METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR; VOMITING;

EID: 80052964847     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/j.ijgo.2011.04.017     Document Type: Article

References (16)

1. D.P. Goldstein, and R.S. Berkowitz Gestational trophoblastic diseases V.T. DeVita, T.S. Lawrence, S.A. Rosenberg, Devita, Hellman & Rosenberg's Cancer: Principles & Practice of Oncology 8th edition 2008 Lippincott Williams & Wilkins Philadelphia 1564 1568
2. E.S. Newlands, K.D. Bagshawe, R.H. Begent, G.J. Rustin, L. Holden, and J. Dent Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984) Br J Obstet Gynaecol 93 1 1986 63 69 (Pubitemid 16133663)
3. M. Bower, E.S. Newlands, L. Holden, D. Short, C. Brock, and G.J. Rustin EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients J Clin Oncol 15 7 1997 2636 2643 (Pubitemid 27289895)
4. P.F. Escobar, J.R. Lurain, D.K. Singh, K. Bozorgi, and D.A. Fishman Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy Gynecol Oncol 91 3 2003 552 557 (Pubitemid 38388149)
5. T. Turan, O. Karacay, G. Tulunay, N. Boran, S. Koc, and S. Bozok Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia Int J Gynecol Cancer 16 3 2006 1432 1438 (Pubitemid 43886781)
6. W.G. Lu, F. Ye, Y.M. Shen, Y.F. Fu, H.Z. Chen, and X.Y. Wan EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients Int J Gynecol Cancer 18 2 2008 357 362 (Pubitemid 351365231)
7. G. Bolis, C. Bonazzi, F. Landoni, G. Mangili, F. Vergadoro, and F. Zanaboni EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT) Gynecol Oncol 31 3 1988 439 444
8. J.T. Soper, A.C. Evans, D.L. Clarke-Pearson, A. Berchuck, G. Rodriguez, and C.B. Hammond ternating weekly chemotherapy with etoposide-methotrexate- dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease Obstet Gynecol 83 1 1994 113 117 (Pubitemid 24027392)
9. M. Quinn, J. Murray, M. Friedlander, S. Steigrad, S. Khoo, and D. Marsden EMACO in high risk gestational trophoblast disease-the Australian experience. Gestational Trophoblast Subcommittee, Clinical Oncological Society of Australia Aust N Z J Obstet Gynecol 34 1 1994 90 92 (Pubitemid 24061519)
10. E.S. Newlands, P.J. Mulholland, L. Holden, M.J. Seckl, and G.J. Rustin Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors J Clin Oncol 18 4 2000 854 859 (Pubitemid 30106617)
11. Y. Mao, X. Wan, W. Lv, and X. Xie Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen Int J Gynecol Obstet 98 1 2007 44 47 (Pubitemid 46898394)
12. Y. Xiang, Z. Sun, X. Wan, and X. Yang EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor J Reprod Med 49 6 2004 443 446 (Pubitemid 38781419)
13. F. Ghaemmaghami, M. Modares, M. Arab, N. Behtash, A.Z. Moosavi, and N. Khanafshar EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II-IV) Int J Gynecol Cancer 14 2 2004 360 365 (Pubitemid 38533910)
14. E.A. Surwit, and J.M. Childers High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen J Reprod Med 36 1 1991 45 48
15. C. Theodore, M. Azab, J.P. Droz, A. Assouline, M. George, and G. Piot Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide Cancer 64 9 1989 1824 1828 (Pubitemid 19267798)
16. J. Wang, D. Short, N.J. Sebire, I. Lindsay, E.S. Newlands, and P. Schmid Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE) Ann Oncol 19 9 2008 1578 1583